Acacia Research (ACTG) Financials

$3.83 -0.03 (-0.78%)

Closing price 04:00 PM Eastern

Extended Trading

$3.82 0.00 (-0.13%)

As of 04:04 PM Eastern

Annual Income Statements for Acacia Research

This table shows Acacia Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-36	67	-125
Consolidated Net Income / (Loss)	-35	69	-111
Net Income / (Loss) Continuing Operations	-35	69	-111
Total Pre-Tax Income	-38	67	-127
Total Operating Income	-33	21	-40
Total Gross Profit	30	72	35
Total Revenue	122	125	72
Operating Revenue	122	125	59
Total Cost of Revenue	93	53	37
Operating Cost of Revenue	93	53	37
Total Operating Expenses	63	51	62
Selling, General & Admin Expense	55	44	53
Marketing Expense	7.22	6.91	8.62
Research & Development Expense	0.00	0.00	0.63
Total Other Income / (Expense), net	-5.22	46	-100
Interest Expense	6.44	2.06	6.43
Other Income / (Expense), net	1.22	49	-94
Income Tax Expense	-3.45	-1.50	-16
Net Income / (Loss) Attributable to Noncontrolling Interest	1.36	1.87	14
Basic Earnings per Share	($0.36)	$0.73	($3.13)
Weighted Average Basic Shares Outstanding	99.21M	75.30M	42.46M
Diluted Earnings per Share	($0.36)	$0.58	($3.13)
Weighted Average Diluted Shares Outstanding	96.09M	99.90M	58.57M
Weighted Average Basic & Diluted Shares Outstanding	96.09M	99.90M	58.57M

This table shows Acacia Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-13	-14	-8.45	-0.37	69	1.64	-19	15	59	28
Consolidated Net Income / (Loss)	-14	-12	-8.83	-0.19	76	2.76	-19	9.45	-19	28
Net Income / (Loss) Continuing Operations	-14	-12	-8.83	-0.19	76	2.76	-19	9.45	-19	28
Total Pre-Tax Income	-15	-6.16	-16	-1.30	73	2.57	-20	12	-20	29
Total Operating Income	-16	-10	-4.76	-2.09	56	-13	-13	-9.32	-15	-11
Total Gross Profit	8.59	2.35	6.76	12	77	1.76	-11	4.85	19	48
Total Revenue	49	23	26	24	101	12	-2.03	15	20	58
Operating Revenue	49	23	26	24	92	10	7.90	15	13	16
Total Cost of Revenue	40	21	19	12	24	9.85	8.94	9.96	0.72	9.93
Operating Cost of Revenue	40	21	19	12	24	9.85	8.94	9.96	0.72	9.93
Total Operating Expenses	24	13	12	14	12	13	11	14	18	17
Selling, General & Admin Expense	22	11	9.95	12	11	12	9.43	12	16	15
Marketing Expense	2.88	1.39	1.39	1.56	1.52	1.61	1.86	1.91	2.19	2.12
Research & Development Expense	-0.42	0.11	0.18	0.13	-0.59	0.17	0.21	0.22	0.14	0.16
Total Other Income / (Expense), net	1.01	4.11	-11	0.79	9.00	14	2.04	21	-12	-1.20
Interest Expense	6.44	0.00	0.00	0.00	0.13	0.13	0.90	0.90	-171	1.07
Other Income / (Expense), net	36	4.11	-11	-28	7.78	14	2.94	24	-183	-0.13
Income Tax Expense	-0.78	5.50	-7.06	-1.11	-2.15	-0.20	-1.65	2.48	-1.81	0.68
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.78	2.34	-0.38	0.19	10	1.13	0.00	-9.45	-0.19	0.31
Basic Earnings per Share	($0.14)	($0.14)	($0.08)	$0.00	$0.99	($0.02)	($0.36)	$0.12	($0.62)	$0.54
Weighted Average Basic Shares Outstanding	99.21M	99.85M	100.08M	99.75M	75.30M	94.33M	58.41M	47.97M	42.46M	38.05M
Diluted Earnings per Share	($0.14)	($0.14)	($0.08)	$0.00	$1.04	($0.03)	($0.36)	($0.07)	($0.10)	$0.02
Weighted Average Diluted Shares Outstanding	96.09M	97.37M	100.38M	99.75M	99.90M	99.89M	299.66M	89.07M	58.57M	43.54M
Weighted Average Basic & Diluted Shares Outstanding	96.09M	97.37M	100.38M	100.02M	99.90M	99.89M	299.66M	58.55M	58.57M	43.54M

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-65	52	-22
Net Cash From Operating Activities	50	-23	-37
Net Cash From Continuing Operating Activities	50	-23	-37
Net Income / (Loss) Continuing Operations	-35	69	-111
Consolidated Net Income / (Loss)	-35	69	-111
Depreciation Expense	34	15	14
Non-Cash Adjustments To Reconcile Net Income	3.97	-30	90
Changes in Operating Assets and Liabilities, net	47	-76	-30
Net Cash From Investing Activities	-213	16	184
Net Cash From Continuing Investing Activities	-213	16	184
Purchase of Property, Plant & Equipment	-149	-0.19	-0.73
Acquisitions	-102	-15	-5.00
Purchase of Investments	-20	-13	-112
Sale and/or Maturity of Investments	58	35	302
Other Investing Activities, net	0.00	9.97	-
Net Cash From Financing Activities	98	59	-166
Net Cash From Continuing Financing Activities	98	59	-166
Repayment of Debt	-30	-68	-120
Repurchase of Common Equity	-20	0.00	-51
Payment of Dividends	0.00	-1.40	-2.80
Issuance of Debt	133	0.00	-
Issuance of Common Equity	15	0.00	-
Other Financing Activities, net	-0.87	128	7.65
Cash Interest Paid	5.06	2.51	7.23
Cash Income Taxes Paid	1.05	0.83	0.38

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-85	-27	-52	99	-4.64	-10	-9.04	76	46	-22
Net Cash From Operating Activities	-20	-0.57	16	55	-4.54	1.16	-15	-4.35	-24	3.96
Net Cash From Continuing Operating Activities	-20	-0.94	16	55	-4.54	1.16	-15	-4.35	-24	3.96
Net Income / (Loss) Continuing Operations	-14	-12	-8.83	-0.19	76	2.76	-19	9.45	-19	28
Consolidated Net Income / (Loss)	-14	-12	-8.83	-0.19	76	2.76	-19	9.45	-19	28
Depreciation Expense	12	9.76	7.41	4.57	4.58	3.36	3.41	3.38	3.37	3.36
Non-Cash Adjustments To Reconcile Net Income	3.23	-1.16	10	-8.47	-12	-12	12	-18	5.27	-35
Changes in Operating Assets and Liabilities, net	-21	2.11	6.92	59	-73	7.00	-11	0.70	-14	7.36
Net Cash From Investing Activities	-96	-7.23	-152	42	7.56	-0.60	6.44	2.78	60	46
Net Cash From Continuing Investing Activities	-96	-7.23	-152	42	7.56	-0.60	6.44	2.78	60	46
Purchase of Property, Plant & Equipment	-3.29	-2.23	-143	-0.27	-0.04	-0.02	-0.05	-0.08	-0.18	-0.14
Acquisitions	-88	-5.00	-	-	-15	-	-	-	-	-
Purchase of Investments	-4.93	-	-	-16	-4.39	-2.84	-0.68	-5.17	-4.61	-
Net Cash From Financing Activities	31	-19	84	1.83	-7.72	-11	-0.67	78	8.47	-68
Net Cash From Continuing Financing Activities	31	-19	84	1.83	-7.72	-11	-0.67	78	8.47	-68
Repayment of Debt	-18	-	-	-	-7.70	-	-	-	-	-55
Repurchase of Common Equity	-13	-	-	-	-	-	-	-	-	-11
Issuance of Debt	62	-	69	2.50	-	-	-	0.00	-	-
Other Financing Activities, net	-0.02	-	-0.17	-0.67	-0.02	49	0.03	79	9.17	-1.02
Cash Interest Paid	2.35	2.26	0.13	0.32	0.13	0.58	1.80	0.00	1.80	0.55
Cash Income Taxes Paid	0.59	0.08	0.27	0.12	0.11	0.17	0.40	0.15	0.18	0.17

This table presents Acacia Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	756	634	483
Total Current Assets	420	555	428
Cash & Equivalents	274	340	288
Short-Term Investments	60	100	98
Accounts Receivable	27	81	8.23
Inventories, net	27	11	14
Prepaid Expenses	32	23	19
Plant, Property, & Equipment, net	24	2.36	3.54
Total Noncurrent Assets	312	77	51
Goodwill	29	8.99	7.54
Intangible Assets	55	34	37
Noncurrent Deferred & Refundable Income Taxes	20	2.92	0.00
Other Noncurrent Operating Assets	207	31	7.21
Total Liabilities & Shareholders' Equity	756	634	483
Total Liabilities	204	44	194
Total Current Liabilities	47	28	87
Accounts Payable	33	12	20
Current Deferred Revenue	1.32	0.98	1.23
Current Employee Benefit Liabilities	6.28	4.21	4.74
Other Current Liabilities	6.99	11	0.70
Total Noncurrent Liabilities	157	16	106
Long-Term Debt	114	11	0.00
Asset Retirement Reserve & Litigation Obligation	31	0.29	-
Noncurrent Deferred & Payable Income Tax Liabilities	2.61	0.00	0.74
Other Noncurrent Operating Liabilities	8.87	5.48	105
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	553	590	269
Total Preferred & Common Equity	515	568	258
Preferred Stock	0.00	0.00	0.00
Total Common Equity	515	568	258
Common Stock	910	906	663
Retained Earnings	-276	-240	-307
Treasury Stock	-119	-98	-98
Accumulated Other Comprehensive Income / (Loss)	-1.18	0.00	-
Noncontrolling Interest	38	21	11

This table presents Acacia Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	708	754	632	529	535	557	485
Total Current Assets	458	494	553	484	486	505	427
Cash & Equivalents	360	387	439	345	355	364	242
Short-Term Investments	51	55	60	101	90	97	159
Accounts Receivable	11	19	15	5.90	6.27	8.67	7.04
Inventories, net	12	12	9.88	12	14	15	14
Prepaid Expenses	24	21	29	20	21	20	5.17
Plant, Property, & Equipment, net	2.37	2.32	2.09	2.65	2.95	3.28	3.70
Total Noncurrent Assets	248	257	76	42	46	48	54
Goodwill	8.99	8.99	8.99	7.54	7.54	7.54	7.47
Intangible Assets	31	36	30	28	31	34	40
Noncurrent Deferred & Refundable Income Taxes	8.42	14	6.57	0.32	-	-	-
Other Noncurrent Operating Assets	199	198	31	6.63	7.84	6.97	7.21
Total Liabilities & Shareholders' Equity	708	754	632	529	535	557	485
Total Liabilities	129	157	42	26	176	179	184
Total Current Liabilities	28	44	26	21	78	90	85
Accounts Payable	14	18	8.69	14	10	21	14
Current Deferred Revenue	1.27	0.91	1.07	1.15	1.02	1.21	1.40
Current Employee Benefit Liabilities	4.97	3.98	4.62	5.20	5.51	5.49	5.07
Other Current Liabilities	7.76	6.41	3.01	1.30	0.58	1.06	3.26
Total Noncurrent Liabilities	101	113	16	4.12	98	89	99
Long-Term Debt	70	82	13	-	-	-	-
Asset Retirement Reserve & Litigation Obligation	28	28	-	-	-	-	-
Other Noncurrent Operating Liabilities	3.02	2.93	2.89	3.62	98	88	95
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	579	597	590	504	335	356	282
Total Preferred & Common Equity	540	561	568	493	324	345	258
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	540	561	568	493	324	345	258
Common Stock	908	907	906	905	739	740	644
Retained Earnings	-262	-248	-240	-314	-316	-297	-288
Treasury Stock	-106	-98	-98	-98	-98	-98	-98
Noncontrolling Interest	38	36	21	11	11	11	25

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-2.23%	72.97%	51.82%
EBITDA Growth	-97.78%	170.05%	-152.22%
EBIT Growth	-145.63%	151.93%	-161.00%
NOPAT Growth	-207.69%	176.26%	-324.11%
Net Income Growth	-150.34%	162.13%	-173.78%
EPS Growth	-162.07%	118.53%	-263.87%
Operating Cash Flow Growth	322.71%	39.72%	-380.17%
Free Cash Flow Firm Growth	-6.18%	-187.79%	-384.48%
Invested Capital Growth	107.73%	452.55%	44.18%
Revenue Q/Q Growth	-32.95%	183.60%	-4.14%
EBITDA Q/Q Growth	-93.66%	147.31%	-128.18%
EBIT Q/Q Growth	-1,111.74%	136.28%	-132.42%
NOPAT Q/Q Growth	-154.15%	161.70%	-628.25%
Net Income Q/Q Growth	-163.29%	374.09%	-198.92%
EPS Q/Q Growth	-143.90%	203.57%	-621.67%
Operating Cash Flow Q/Q Growth	-23.87%	46.03%	-514.57%
Free Cash Flow Firm Q/Q Growth	-42.31%	-40.49%	70.36%
Invested Capital Q/Q Growth	40.05%	178.15%	-16.93%
Profitability Metrics	-	-	-
Gross Margin	24.24%	57.77%	48.31%
EBITDA Margin	1.53%	67.32%	-166.22%
Operating Margin	-26.92%	16.74%	-55.43%
EBIT Margin	-25.92%	55.55%	-185.03%
Profit (Net Income) Margin	-28.37%	55.10%	-153.39%
Tax Burden Percent	90.96%	102.23%	87.25%
Interest Burden Percent	120.31%	97.03%	95.02%
Effective Tax Rate	0.00%	-2.23%	0.00%
Return on Invested Capital (ROIC)	-9.35%	37.29%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-5.76%	24.85%	0.00%
Return on Net Nonoperating Assets (RNNOA)	3.27%	-21.61%	0.00%
Return on Equity (ROE)	-6.08%	15.69%	-30.21%
Cash Return on Invested Capital (CROIC)	-79.37%	-115.01%	0.00%
Operating Return on Assets (OROA)	-4.56%	12.45%	-20.88%
Return on Assets (ROA)	-4.99%	12.35%	-17.31%
Return on Common Equity (ROCE)	-5.76%	14.75%	-27.87%
Return on Equity Simple (ROE_SIMPLE)	-6.74%	12.13%	-42.95%
Net Operating Profit after Tax (NOPAT)	-23	21	-28
NOPAT Margin	-18.84%	17.11%	-38.80%
Net Nonoperating Expense Percent (NNEP)	-3.59%	12.44%	-19.24%
Return On Investment Capital (ROIC_SIMPLE)	-3.46%	3.57%	-
Cost of Revenue to Revenue	75.76%	42.23%	51.69%
SG&A Expenses to Revenue	45.26%	35.51%	72.84%
R&D to Revenue	0.00%	0.00%	0.87%
Operating Expenses to Revenue	51.16%	41.04%	85.62%
Earnings before Interest and Taxes (EBIT)	-32	69	-134
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.87	84	-120
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.82	0.69	0.71
Price to Tangible Book Value (P/TBV)	0.98	0.74	0.86
Price to Revenue (P/Rev)	3.45	3.13	2.53
Price to Earnings (P/E)	0.00	5.84	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	17.13%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.72	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.97	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	128.94	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	4.80	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.21	0.02	0.21
Long-Term Debt to Equity	0.21	0.02	0.00
Financial Leverage	-0.57	-0.87	-1.17
Leverage Ratio	1.22	1.27	1.75
Compound Leverage Factor	1.46	1.23	1.66
Debt to Total Capital	17.10%	1.75%	17.29%
Short-Term Debt to Total Capital	0.00%	0.00%	17.29%
Long-Term Debt to Total Capital	17.10%	1.75%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.67%	3.56%	8.86%
Common Equity to Total Capital	77.23%	94.69%	73.86%
Debt to EBITDA	61.09	0.13	-0.50
Net Debt to EBITDA	-117.78	-5.10	2.71
Long-Term Debt to EBITDA	61.09	0.13	0.00
Debt to NOPAT	-4.95	0.49	-2.15
Net Debt to NOPAT	9.54	-20.06	11.61
Long-Term Debt to NOPAT	-4.95	0.49	0.00
Altman Z-Score	1.35	6.37	-0.24
Noncontrolling Interest Sharing Ratio	5.18%	5.95%	7.73%
Liquidity Ratios	-	-	-
Current Ratio	8.89	20.06	4.91
Quick Ratio	7.64	18.83	4.52
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-196	-184	-64
Operating Cash Flow to CapEx	33.71%	-11,907.94%	-5,100.55%
Free Cash Flow to Firm to Interest Expense	-30.39	-89.32	-9.95
Operating Cash Flow to Interest Expense	7.78	-10.91	-5.80
Operating Cash Flow Less CapEx to Interest Expense	-15.30	-11.00	-5.92
Efficiency Ratios	-	-	-
Asset Turnover	0.18	0.22	0.11
Accounts Receivable Turnover	2.28	2.82	8.15
Inventory Turnover	4.83	4.20	3.23
Fixed Asset Turnover	9.33	42.46	18.74
Accounts Payable Turnover	4.18	3.33	2.35
Days Sales Outstanding (DSO)	160.35	129.52	44.78
Days Inventory Outstanding (DIO)	75.64	86.86	113.01
Days Payable Outstanding (DPO)	87.28	109.72	155.03
Cash Conversion Cycle (CCC)	148.71	106.66	2.76
Capital & Investment Metrics	-	-	-
Invested Capital	333	160	-45
Invested Capital Turnover	0.50	2.18	-1.14
Increase / (Decrease) in Invested Capital	173	206	36
Enterprise Value (EV)	241	-16	-111
Market Capitalization	423	392	183
Book Value per Share	$5.29	$5.69	$6.08
Tangible Book Value per Share	$4.42	$5.26	$5.04
Total Capital	667	600	350
Total Debt	114	11	60
Total Long-Term Debt	114	11	0.00
Net Debt	-220	-429	-326
Capital Expenditures (CapEx)	149	0.19	0.73
Debt-free, Cash-free Net Working Capital (DFCFNWC)	39	87	15
Debt-free Net Working Capital (DFNWC)	373	527	401
Net Working Capital (NWC)	373	527	341
Net Nonoperating Expense (NNE)	12	-48	83
Net Nonoperating Obligations (NNO)	-220	-429	-335
Total Depreciation and Amortization (D&A)	34	15	14
Debt-free, Cash-free Net Working Capital to Revenue	32.00%	69.52%	20.85%
Debt-free Net Working Capital to Revenue	304.88%	421.16%	554.75%
Net Working Capital to Revenue	304.88%	421.16%	471.17%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.36)	$0.73	($3.13)
Adjusted Weighted Average Basic Shares Outstanding	99.21M	75.30M	42.46M
Adjusted Diluted Earnings per Share	($0.36)	$0.58	($3.13)
Adjusted Weighted Average Diluted Shares Outstanding	96.09M	99.90M	58.57M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	96.09M	99.90M	58.57M
Normalized Net Operating Profit after Tax (NOPAT)	-23	15	-28
Normalized NOPAT Margin	-18.84%	11.71%	-38.80%
Pre Tax Income Margin	-31.19%	53.90%	-175.80%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-4.92	33.68	-20.81
NOPAT to Interest Expense	-3.58	10.37	-4.36
EBIT Less CapEx to Interest Expense	-28.01	33.59	-20.92
NOPAT Less CapEx to Interest Expense	-26.67	10.28	-4.48
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	2.03%	-2.52%
Augmented Payout Ratio	-58.47%	2.03%	-48.48%

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-51.51%	100.79%	1,372.18%	64.29%	410.47%	-79.82%	88.98%	9.60%	-13.67%	3,535.65%
EBITDA Growth	-52.65%	-20.54%	-37.28%	-245.64%	135.22%	156.00%	15.00%	-80.27%	-154.96%	-128.50%
EBIT Growth	-67.82%	-626.50%	-65.71%	-312.52%	132.30%	110.18%	10.26%	-83.43%	-156.49%	-144.94%
NOPAT Growth	-119.22%	49.23%	62.02%	80.21%	665.36%	-27.60%	-120.97%	-23.97%	-136.32%	12.74%
Net Income Growth	-118.57%	-522.05%	52.98%	-102.00%	506.37%	-90.27%	60.46%	112.89%	-109.08%	-68.36%
EPS Growth	-113.46%	-366.67%	77.78%	100.00%	1,140.00%	-250.00%	75.00%	95.65%	-102.75%	-97.67%
Operating Cash Flow Growth	-345.91%	-149.22%	209.09%	1,360.96%	80.86%	-70.67%	-2.66%	-37.50%	-205.02%	416.15%
Free Cash Flow Firm Growth	-24.03%	-69.25%	-421.46%	-549.44%	-220.90%	52.40%	73.92%	90.49%	-221.36%	-166.25%
Invested Capital Growth	107.73%	312.59%	1,019.60%	457.02%	452.55%	248.21%	62.11%	31.43%	44.18%	85.06%
Revenue Q/Q Growth	109.54%	-9.78%	6.24%	-77.68%	767.61%	671.59%	-113.72%	-24.98%	-65.69%	412.10%
EBITDA Q/Q Growth	797.83%	142.45%	66.84%	-142.71%	1,406.57%	173.34%	-135.18%	109.06%	-2,295.89%	-11.30%
EBIT Q/Q Growth	432.81%	61.23%	47.31%	-154.49%	5,345.90%	112.20%	-167.57%	107.19%	-1,616.97%	-7.54%
NOPAT Q/Q Growth	-53.90%	-115.89%	-127.98%	-102.44%	506.53%	-61.49%	-18.78%	27.50%	8.25%	-179.66%
Net Income Q/Q Growth	-20.30%	-32.03%	-4,571.43%	-100.25%	2,633.53%	114.71%	-298.78%	150.85%	-165.43%	159.79%
EPS Q/Q Growth	0.00%	-75.00%	0.00%	-100.00%	3,566.67%	91.67%	-414.29%	30.00%	-600.00%	101.39%
Operating Cash Flow Q/Q Growth	-3,448.51%	-103.54%	-70.61%	1,306.84%	-491.72%	107.85%	-239.69%	81.68%	-700.20%	127.48%
Free Cash Flow Firm Q/Q Growth	1.91%	29.58%	-97.20%	7.49%	-33.86%	-116.95%	-145.60%	55.01%	80.15%	-18.85%
Invested Capital Q/Q Growth	40.05%	0.35%	127.29%	-34.97%	178.15%	323.67%	11.76%	35.78%	-16.93%	42.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.59%	10.09%	26.16%	49.16%	76.09%	15.18%	0.00%	32.73%	96.35%	82.74%
EBITDA Margin	66.21%	15.45%	-32.84%	-105.23%	67.80%	39.05%	0.00%	118.71%	-982.83%	-14.07%
Operating Margin	-32.37%	-44.07%	-18.41%	-8.58%	55.54%	-113.30%	0.00%	-62.99%	-73.74%	-19.76%
EBIT Margin	41.97%	-26.43%	-61.50%	-124.01%	63.26%	10.08%	0.00%	95.87%	-999.93%	-19.98%
Profit (Net Income) Margin	-28.71%	-50.01%	-34.17%	-0.78%	74.96%	23.79%	0.00%	63.82%	-94.16%	49.37%
Tax Burden Percent	94.76%	189.24%	55.56%	14.56%	102.92%	107.68%	91.95%	79.19%	91.11%	97.66%
Interest Burden Percent	-72.19%	100.00%	100.00%	4.30%	115.13%	219.23%	212.99%	84.07%	10.34%	-253.02%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	-2.92%	-7.68%	0.00%	20.81%	0.00%	2.34%
Return on Invested Capital (ROIC)	-11.24%	-38.12%	-20.85%	-22.88%	124.62%	-574.45%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-10.33%	-36.98%	-19.37%	-23.17%	119.93%	-578.76%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	5.87%	26.89%	15.09%	21.37%	-104.26%	565.28%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-5.37%	-11.23%	-5.76%	-1.51%	20.35%	-9.17%	0.15%	-7.64%	-30.21%	41.78%
Cash Return on Invested Capital (CROIC)	-79.37%	-93.13%	-92.98%	-98.43%	-115.01%	-227.69%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	7.39%	-7.80%	-16.30%	-29.82%	14.18%	0.88%	0.00%	11.59%	-112.84%	-2.44%
Return on Assets (ROA)	-5.05%	-14.75%	-9.06%	-0.19%	16.80%	2.07%	0.00%	7.71%	-10.63%	6.03%
Return on Common Equity (ROCE)	-5.09%	-10.71%	-5.34%	-1.43%	19.14%	-8.55%	0.13%	-7.03%	-27.87%	37.49%
Return on Equity Simple (ROE_SIMPLE)	0.00%	10.15%	12.35%	10.43%	0.00%	-5.11%	0.15%	-8.19%	0.00%	43.52%
Net Operating Profit after Tax (NOPAT)	-11	-7.19	-3.33	-1.46	58	-14	-8.77	-7.38	-10	-11
NOPAT Margin	-22.66%	-30.85%	-12.89%	-6.01%	57.17%	-122.00%	0.00%	-49.88%	-51.62%	-19.30%
Net Nonoperating Expense Percent (NNEP)	-0.91%	-1.14%	-1.48%	0.29%	4.69%	4.31%	-2.71%	4.15%	-1.95%	9.45%
Return On Investment Capital (ROIC_SIMPLE)	-1.66%	-	-	-	9.59%	-	-	-	-	-
Cost of Revenue to Revenue	82.41%	89.91%	73.84%	50.84%	23.91%	84.82%	0.00%	67.27%	3.65%	17.26%
SG&A Expenses to Revenue	44.91%	47.72%	38.51%	50.79%	11.28%	99.97%	0.00%	81.33%	80.42%	26.15%
R&D to Revenue	-0.86%	0.46%	0.69%	0.55%	-0.59%	1.48%	0.00%	1.46%	0.68%	0.27%
Operating Expenses to Revenue	49.95%	54.15%	44.57%	57.74%	12.20%	115.34%	0.00%	95.72%	92.21%	30.10%
Earnings before Interest and Taxes (EBIT)	21	-6.16	-16	-30	64	1.17	-9.59	14	-197	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	32	3.60	-8.49	-26	68	4.53	-6.18	18	-194	-8.09
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.82	0.87	0.89	0.94	0.69	0.74	0.75	0.66	0.71	0.60
Price to Tangible Book Value (P/TBV)	0.98	0.93	0.97	1.01	0.74	0.80	0.85	0.74	0.86	0.74
Price to Revenue (P/Rev)	3.45	2.56	2.94	3.73	3.13	8.27	2.71	3.07	2.53	2.05
Price to Earnings (P/E)	0.00	10.17	8.13	10.38	5.84	6.41	2.92	5.57	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	9.83%	12.30%	9.63%	17.13%	15.59%	34.20%	17.95%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.72	0.70	0.75	0.66	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.97	0.91	1.04	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	128.94	5.61	5.84	2.09	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	52.72	16.94	4.08	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	3.88	4.18	2.22	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	4.80	2.51	2.62	1.86	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.21	0.12	0.14	0.02	0.02	0.00	0.17	0.16	0.21	0.20
Long-Term Debt to Equity	0.21	0.12	0.14	0.02	0.02	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.73	-0.78	-0.92	-0.87	-0.98	-1.15	-1.10	-1.17	-1.56
Leverage Ratio	1.22	1.14	1.35	1.23	1.27	1.26	1.70	1.65	1.75	2.30
Compound Leverage Factor	-0.88	1.14	1.35	0.05	1.46	2.76	3.63	1.39	0.18	-5.82
Debt to Total Capital	17.10%	10.79%	12.08%	2.16%	1.75%	0.00%	14.43%	13.99%	17.29%	16.93%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.43%	13.99%	17.29%	16.93%
Long-Term Debt to Total Capital	17.10%	10.79%	12.08%	2.16%	1.75%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.67%	5.92%	5.31%	3.54%	3.56%	2.19%	8.16%	7.42%	8.86%	11.94%
Common Equity to Total Capital	77.23%	83.29%	82.61%	94.30%	94.69%	97.81%	77.41%	78.59%	73.86%	71.13%
Debt to EBITDA	61.09	2.38	2.70	0.40	0.13	0.00	-0.32	-0.32	-0.50	0.14
Net Debt to EBITDA	-117.78	-11.58	-11.85	-14.85	-5.10	0.00	2.02	2.09	2.71	-0.80
Long-Term Debt to EBITDA	61.09	2.38	2.70	0.40	0.13	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-4.95	1.64	1.94	0.42	0.49	0.00	-0.50	-2.14	-2.15	11.55
Net Debt to NOPAT	9.54	-8.01	-8.49	-15.75	-20.06	0.00	3.15	13.98	11.61	-63.97
Long-Term Debt to NOPAT	-4.95	1.64	1.94	0.42	0.49	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.58	2.61	2.33	8.12	6.34	8.87	1.03	1.12	-0.67	0.59
Noncontrolling Interest Sharing Ratio	5.18%	4.57%	7.35%	5.57%	5.95%	6.75%	11.86%	8.05%	7.73%	10.28%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	8.89	16.39	11.17	21.40	20.06	22.60	6.24	5.60	4.91	5.00
Quick Ratio	7.64	15.10	10.42	19.88	18.83	21.08	5.80	5.21	4.52	4.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-184	-187	-266	-135	-148	-111	-51	-21	-46	-232
Operating Cash Flow to CapEx	-615.87%	-25.56%	11.28%	20,310.74%	-12,281.08%	7,733.33%	-27,357.41%	-5,239.76%	-13,187.78%	2,785.21%
Free Cash Flow to Firm to Interest Expense	-28.53	0.00	0.00	0.00	-1,113.50	-851.03	-56.66	-23.07	0.00	-216.82
Operating Cash Flow to Interest Expense	-3.15	0.00	0.00	0.00	-34.17	8.92	-16.41	-4.83	0.00	3.69
Operating Cash Flow Less CapEx to Interest Expense	-3.66	0.00	0.00	0.00	-34.44	8.81	-16.47	-4.92	0.00	3.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.18	0.30	0.27	0.24	0.22	0.09	0.16	0.12	0.11	0.12
Accounts Receivable Turnover	2.28	21.94	13.64	11.89	2.82	6.82	9.02	8.27	8.15	5.20
Inventory Turnover	4.83	6.22	4.97	4.49	4.20	2.25	2.27	2.41	3.23	0.00
Fixed Asset Turnover	9.33	72.78	64.85	53.26	42.46	13.90	26.35	20.56	18.74	0.00
Accounts Payable Turnover	4.18	5.52	4.56	3.71	3.33	2.09	2.62	1.77	2.35	4.90
Days Sales Outstanding (DSO)	160.35	16.64	26.77	30.71	129.52	53.52	40.46	44.14	44.78	70.13
Days Inventory Outstanding (DIO)	75.64	58.68	73.41	81.30	86.86	162.12	160.95	151.33	113.01	0.00
Days Payable Outstanding (DPO)	87.28	66.12	79.98	98.46	109.72	174.28	139.42	206.48	155.03	74.48
Cash Conversion Cycle (CCC)	148.71	9.19	20.20	13.55	106.66	41.36	62.00	-11.00	2.76	-4.36
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	333	238	237	104	160	58	-26	-29	-45	-39
Invested Capital Turnover	0.50	1.24	1.62	3.81	2.18	4.71	-1.92	-2.05	-1.14	-0.50
Increase / (Decrease) in Invested Capital	173	180	263	133	206	96	42	13	36	221
Enterprise Value (EV)	241	165	177	68	-16	-70	-107	-142	-111	-142
Market Capitalization	423	468	501	532	392	365	244	226	183	155
Book Value per Share	$5.29	$5.38	$5.61	$5.69	$5.69	$4.93	$5.54	$5.88	$6.08	$6.73
Tangible Book Value per Share	$4.42	$4.98	$5.16	$5.30	$5.26	$4.58	$4.89	$5.18	$5.04	$5.50
Total Capital	667	649	679	603	600	504	419	439	350	362
Total Debt	114	70	82	13	11	0.00	60	61	60	61
Total Long-Term Debt	114	70	82	13	11	0.00	0.00	0.00	0.00	0.00
Net Debt	-220	-341	-360	-485	-429	-446	-384	-400	-326	-340
Capital Expenditures (CapEx)	3.29	2.23	143	0.27	0.04	0.02	0.05	0.08	0.18	0.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	39	19	7.82	29	87	17	24	15	15	1.93
Debt-free Net Working Capital (DFNWC)	373	430	450	527	527	463	468	476	401	403
Net Working Capital (NWC)	373	430	450	527	527	463	408	415	341	342
Net Nonoperating Expense (NNE)	2.96	4.47	5.50	-1.27	-18	-17	10	-17	8.39	-39
Net Nonoperating Obligations (NNO)	-220	-341	-360	-485	-429	-446	-384	-406	-335	-340
Total Depreciation and Amortization (D&A)	12	9.76	7.41	4.57	4.58	3.36	3.41	3.38	3.37	3.40
Debt-free, Cash-free Net Working Capital to Revenue	32.00%	10.32%	4.58%	20.21%	69.52%	38.58%	26.27%	19.87%	20.85%	2.56%
Debt-free Net Working Capital to Revenue	304.88%	235.56%	263.42%	369.10%	421.16%	1,049.63%	520.37%	647.00%	554.75%	534.29%
Net Working Capital to Revenue	304.88%	235.56%	263.42%	369.10%	421.16%	1,049.63%	453.22%	563.67%	471.17%	452.97%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.14)	($0.14)	($0.08)	$0.00	$0.99	($0.02)	($0.36)	$0.12	($0.62)	$0.54
Adjusted Weighted Average Basic Shares Outstanding	99.21M	99.85M	100.08M	99.75M	75.30M	94.33M	58.41M	47.97M	42.46M	38.05M
Adjusted Diluted Earnings per Share	($0.14)	($0.14)	($0.08)	$0.00	$1.04	($0.03)	($0.36)	($0.07)	($0.10)	$0.02
Adjusted Weighted Average Diluted Shares Outstanding	96.09M	97.37M	100.38M	99.75M	99.90M	99.89M	299.66M	89.07M	58.57M	43.54M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	96.09M	97.37M	100.38M	100.02M	99.90M	99.89M	299.66M	58.55M	58.57M	43.54M
Normalized Net Operating Profit after Tax (NOPAT)	-11	-7.19	-3.33	-1.46	39	-9.21	-8.77	-7.38	-10	-11
Normalized NOPAT Margin	-22.66%	-30.85%	-12.89%	-6.01%	38.88%	-79.31%	0.00%	-49.88%	-51.62%	-19.30%
Pre Tax Income Margin	-30.30%	-26.43%	-61.50%	-5.34%	72.83%	22.09%	0.00%	80.59%	-103.35%	50.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.18	0.00	0.00	0.00	479.08	9.00	-10.65	15.77	0.00	-10.72
NOPAT to Interest Expense	-1.72	0.00	0.00	0.00	432.92	-108.95	-9.74	-8.20	0.00	-10.35
EBIT Less CapEx to Interest Expense	2.67	0.00	0.00	0.00	478.80	8.88	-10.71	15.68	0.00	-10.85
NOPAT Less CapEx to Interest Expense	-2.23	0.00	0.00	0.00	432.64	-109.06	-9.80	-8.30	0.00	-10.49
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	1.18%	2.03%	-8.35%	577.32%	-9.92%	-2.52%	2.47%
Augmented Payout Ratio	-58.47%	13.32%	0.00%	1.18%	2.03%	-8.35%	577.32%	-9.92%	-48.48%	51.51%

Frequently Asked Questions About Acacia Research's Financials

When does Acacia Research's financial year end?

According to the most recent income statement we have on file, Acacia Research's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Acacia Research's net income changed over the last 2 years?

Acacia Research's net income appears to be on a downward trend, with a most recent value of -$34.70 million in 2024, falling from -$110.94 million in 2022. The previous period was $68.93 million in 2023.

What is Acacia Research's operating income?

Acacia Research's total operating income in 2024 was -$32.93 million, based on the following breakdown:

Total Gross Profit: $29.65 million
Total Operating Expenses: $62.58 million

How has Acacia Research revenue changed over the last 2 years?

Over the last 2 years, Acacia Research's total revenue changed from $72.33 million in 2022 to $122.31 million in 2024, a change of 69.1%.

How much debt does Acacia Research have?

Acacia Research's total liabilities were at $203.78 million at the end of 2024, a 363.8% increase from 2023, and a 5.2% increase since 2022.

How much cash does Acacia Research have?

In the past 2 years, Acacia Research's cash and equivalents has ranged from $273.88 million in 2024 to $340.09 million in 2023, and is currently $273.88 million as of their latest financial filing in 2024.

How has Acacia Research's book value per share changed over the last 2 years?

Over the last 2 years, Acacia Research's book value per share changed from 6.08 in 2022 to 5.29 in 2024, a change of -13.1%.

Related Companies

This page (NASDAQ:ACTG) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acacia Research (ACTG) Financials

Frequently Asked Questions About Acacia Research's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acacia Research (ACTG) Financials

Annual Income Statements for Acacia Research

Quarterly Income Statements for Acacia Research

Annual Cash Flow Statements for Acacia Research

Quarterly Cash Flow Statements for Acacia Research

Annual Balance Sheets for Acacia Research

Quarterly Balance Sheets for Acacia Research

Annual Metrics And Ratios for Acacia Research

Quarterly Metrics And Ratios for Acacia Research

Frequently Asked Questions About Acacia Research's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools